1 Industry Outlook
1.1 Market Overview
1.2 Total Addressable Market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Advantages of Blood Glucose Monitoring Systems
3.3 Segmented Addressable Market (SAM)
3.4 Trends of the Blood Glucose Monitoring Systems Market
3.5 Related Markets
3.5.1 Insulin Pump
3.5.2 Smart Insulin Pen
3.5.3 Insulin Syringes
4 Market Outlook
4.1 Evolution of Blood Glucose Monitoring
4.2 Market Segmentation
4.3 PEST Analysis
4.4 Porter 5 (Five) Forces
5 Market Characteristics
5.1 DRO – Global Blood Glucose Monitoring Systems Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing incidence of diabetes across various geographies
5.1.1.2 Increasing number of product launch and approvals
5.1.1.3 Huge surge in the aging population
5.1.2 Opportunities
5.1.2.1 New collaboration and funding to develop new devices
5.1.2.2 Growing patient awareness
5.1.3 Restraints
5.1.3.1 High cost and inadequate reimbursement
5.1.3.2 Product recalls
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 Products: Market Size & Analysis
6.1 Overview
6.2 Self-monitoring Blood Glucose Systems
6.3 Continuous Blood Glucose Monitoring Systems
7 Application: Market Size & Analysis
7.1 Overview
7.2 Type 1 Diabetes
7.3 Type 2 Diabetes
7.4 Gestational Diabetes
8 End-Users: Market Size and Analysis
8.1 Overview
8.2 Hospitals
8.3 Homecare
8.4 Private Clinics
8.5 Others
9 Regions: Market Size and Analysis
9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World
10 Competitive Landscape
10.1 Overview
11 Vendor Profiles
11.1 Medtronic plc
11.1.1 Overview
11.1.2 Medtronic plc: Recent Developments
11.1.3 Business Units
11.1.4 Geographic Revenue
11.1.5 Business Focus
11.1.6 SWOT Analysis
11.1.7 Business Strategies
11.2 Abbott Laboratories
11.2.1 Overview
11.2.2 Abbott Laboratories: Recent Developments
11.2.3 Business Units
11.2.4 Geographic Revenue
11.2.5 Business Focus
11.2.6 SWOT Analysis
11.2.7 Business Strategies
11.3 Johnson and Johnson
11.3.1 Overview
11.3.2 Business Units
11.3.3 Geographic Revenue
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 Overview
11.4.2 Business Units
11.4.3 Geographic Revenue
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
12 Companies to Watch for
12.1 Dexcom
12.1.1 Overview
12.2 PHC Holdings Corporation
12.2.1 Overview
12.3 Ypsomed Holding
12.3.1 Overview
12.4 B. Braun Melsungen AG
12.4.1 Overview
12.5 Trividia Health Inc.
12.5.1 Overview
12.6 Acon Laboratories
12.6.1 Overview
12.7 Sanofi S.A.
12.7.1 Overview
12.8 Arkray, Inc.
12.8.1 Overview
12.9 Nova Biomedical Corporation
12.9.1 Overview
12.10 Prodigy Diabetes Care, LLC
12.10.1 Overview
12.11 Terumo Medical Corporation
12.11.1 Overview
Annexure
Ø Abbreviations
